Le Lézard
Classified in: Health
Subjects: NPT, PER, VET

Command Sergeant Major Joins Wounded Warrior Project Board of Directors


JACKSONVILLE, Fla., Jan. 29, 2018 /PRNewswire-USNewswire/ -- Wounded Warrior Project® (WWP) added a career soldier and leader to its Board of Directors with the unanimous election of Command Sgt. Maj. (Ret.) Alonzo Smith.

Wounded Warrior Project unanimously elected Command Sergeant Major Alonzo Smith to its Board of Directors. CSM Smith served 33 years in the U.S. Army.

CSM Smith joined the Army in 1984. During his 33-year career, he rose through the ranks to command sergeant major, a rank that just 1 percent of enlisted service members reach. CSM Smith has deployed around the world and served in combat during Operation Enduring Freedom (Afghanistan) and Operation Iraqi Freedom.

His military awards and decorations include the Purple Heart, Distinguished Service Medal, Bronze Star, and several others commensurate with his distinguished career. CSM Smith sustained severe wounds in Afghanistan in 2010, when an 82 mm recoilless rifle round struck his vehicle. Following his injury, CSM Smith underwent numerous surgeries, prolonged hospital stays, and extensive physical rehabilitation. CSM Smith also dealt with depression from his wounds and the uncertainty of recovery. He is a role model for all warriors and openly shares his personal experiences with post-traumatic stress to encourage warriors to seek help during recovery. He is a registered alumnus with WWP.

"Command Sergeant Major Alonzo Smith brings a long, decorated military career to Wounded Warrior Project's board," said WWP CEO Lt. Gen. (Ret.) Mike Linnington. "His combat service as an enlisted leader of young men and women brings unprecedented experience to the board, which will enable us to better serve warriors and their families."

CSM Smith's final assignment was at Fort Hood, Texas, where he served as III (U.S. Army) Corps command sergeant major from 2014 until 2017. He retired at Fort Campbell, Kentucky, a post where he served for almost 10 years.

WWP has grown its board by electing seven directors since late 2016. The board comprises individuals with experience in military, business, nonprofit, government, medical, and education fields. In his new role as director, CSM Smith will help the board fulfill WWP's mission to honor and empower Wounded Warriors through governance, guidance, and leadership. Learn more about the board at https://www.woundedwarriorproject.org/mission/board-of-directors.

About Wounded Warrior Project
Wounded Warrior Project® (WWP) connects, serves, and empowers wounded warriors. Read more at http://newsroom.woundedwarriorproject.org/about-us.

SOURCE Wounded Warrior Project


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: